Unknown

Dataset Information

0

Valproate Induces the Unfolded Protein Response by Increasing Ceramide Levels.


ABSTRACT: Bipolar disorder (BD), which is characterized by depression and mania, affects 1-2% of the world population. Current treatments are effective in only 40-60% of cases and cause severe side effects. Valproate (VPA) is one of the most widely used drugs for the treatment of BD, but the therapeutic mechanism of action of this drug is not understood. This knowledge gap has hampered the development of effective treatments. To identify candidate pathways affected by VPA, we performed a genome-wide expression analysis in yeast cells grown in the presence or absence of the drug. VPA caused up-regulation of FEN1 and SUR4, encoding fatty acid elongases that catalyze the synthesis of very long chain fatty acids (C24 to C26) required for ceramide synthesis. Interestingly, fen1? and sur4? mutants exhibited VPA sensitivity. In agreement with increased fatty acid elongase gene expression, VPA increased levels of phytoceramide, especially those containing C24-C26 fatty acids. Consistent with an increase in ceramide, VPA decreased the expression of amino acid transporters, increased the expression of ER chaperones, and activated the unfolded protein response element (UPRE), suggesting that VPA induces the UPR pathway. These effects were rescued by supplementation of inositol and similarly observed in inositol-starved ino1? cells. Starvation of ino1? cells increased expression of FEN1 and SUR4, increased ceramide levels, decreased expression of nutrient transporters, and induced the UPR. These findings suggest that VPA-mediated inositol depletion induces the UPR by increasing the de novo synthesis of ceramide.

SUBMITTER: Jadhav S 

PROVIDER: S-EPMC5064004 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Valproate Induces the Unfolded Protein Response by Increasing Ceramide Levels.

Jadhav Shyamalagauri S   Russo Sarah S   Cottier Stéphanie S   Schneiter Roger R   Cowart Ashley A   Greenberg Miriam L ML  

The Journal of biological chemistry 20160901 42


Bipolar disorder (BD), which is characterized by depression and mania, affects 1-2% of the world population. Current treatments are effective in only 40-60% of cases and cause severe side effects. Valproate (VPA) is one of the most widely used drugs for the treatment of BD, but the therapeutic mechanism of action of this drug is not understood. This knowledge gap has hampered the development of effective treatments. To identify candidate pathways affected by VPA, we performed a genome-wide expre  ...[more]

Similar Datasets

| S-EPMC2903364 | biostudies-literature
| S-EPMC8501768 | biostudies-literature
| S-EPMC5158320 | biostudies-literature
| S-EPMC4603647 | biostudies-literature
| S-EPMC5797042 | biostudies-literature
| S-EPMC2918880 | biostudies-literature
| S-EPMC4600627 | biostudies-literature
| S-EPMC4106898 | biostudies-literature
| S-EPMC9820188 | biostudies-literature
| S-EPMC8706696 | biostudies-literature